A siRNA Mediated Screen During C2C12 Myogenesis
Myogenesis is a multistep process taking place during pre- and postnatal stages for muscle formation, growth, and regeneration. It is a highly regulated process involving many molecular factors which act during myoblast proliferation and differentiation. To provide new insights into the molecular mechanisms and interactions behind the regulation of these different steps, RNA interference is an efficient methodology to implement. We developed a high-throughput siRNA screen in C2C12 murine myoblast cells for identification of genes relevant to signaling pathways controlling muscle growth. The proposed protocol is based on (1) the analyses of a maximum number of cells/myotubes to detect and quantify both clear and subtle phenotypes during proliferation/fusion cells and (2) the use of two cellular fluorescent markers, DAPI and myosin, decorating nuclei and myotubes respectively. Four phenotypic criteria were quantitatively assessed: cellular density, myotubes quantity, fusion index, and size and morphology of myotubes.
Key wordssiRNA Functional screen Myogenesis C2C12 Quantitative-imaging analysis Proliferation Differentiation Immunostaining
- 3.Pownall ME, Gustafsson MK, Emerson CP (2002) Myogenic regulatory factors and the specification of muscle progenitors in vertebrate embryos. Annu Rev Cell Dev Biol 18:747–783. https://doi.org/10.1146/annurev.cellbio.18.012502.105758CrossRefGoogle Scholar
- 29.Khanjyan MV, Yang J, Kayali R et al (2013) A high-content, high-throughput siRNA screen identifies cyclin D2 as a potent regulator of muscle progenitor cell fusion and a target to enhance muscle regeneration. Hum Mol Genet 22:3283–3295. https://doi.org/10.1093/hmg/ddt184CrossRefPubMedPubMedCentralGoogle Scholar
- 31.Rajan S, Chu Pham Dang H, Djambazian H et al (2012) Analysis of early C2C12 myogenesis identifies stably and differentially expressed transcriptional regulators whose knock-down inhibits myoblast differentiation. Physiol Genomics 44:183–197. https://doi.org/10.1152/physiolgenomics.00093.2011CrossRefPubMedGoogle Scholar